Growth Inhibition of Multiple Myeloma Cells by a Novel I B Kinase Inhibitor (original) (raw)
2005, Clinical Cancer Research
visibility
…
description
10 pages
link
1 file
Related papers
STK405759 as a novel drug for Multiple Myeloma therapy
Clinical Lymphoma Myeloma and Leukemia, 2015
Redesigning Kinase Inhibitors to Enhance Specificity
Journal of Medicinal Chemistry, 2008
Understanding how kinase-targeted therapies work
Cell Cycle, 2008
Specific delivery of kinase inhibitors in nonmalignant and malignant diseases
Expert Opinion on Drug Delivery, 2011
Therapeutic Options in the Treatment of Multiple Myeloma
PharmacoEconomics, 1999
Journal of Biological Chemistry, 2003
Recent progress in cancer therapeutics
Translational oncology, 2009
Clinical Cancer Research, 2011
Inhibitors that target protein kinases for the treatment of ovarian carcinoma
American Journal of Obstetrics and Gynecology, 2003
A novel anti-melanoma SRC-family kinase inhibitor
Oncotarget, 2019
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Related papers
Anti-Cancer Drugs, 2014
Hematologic toxicities of small molecule tyrosine kinase inhibitors
Targeted Oncology, 2011
ErbB receptor tyrosine kinase inhibitors as therapeutic agents
Frontiers in Bioscience, 2002
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Annals of Hematology, 2020
Cancer Chemotherapy: Combination with Inhibitors (Volume I)
Cancers, 2024
Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase
Journal of Medicinal Chemistry, 2012
Ikaros, CK2 kinase, and the road to leukemia
Molecular and Cellular Biochemistry, 2011
Strategies for Specific Drug Targeting to Tumour Cells
Methods and Principles in Medicinal Chemistry, 2001
Tyrosine Kinase Inhibitors Suppress the Growth of Non-Hodgkin B Lymphomas
Journal of Pharmacology and Experimental Therapeutics, 2002
Therapeutic effects of IkB kinase inhibitor during systemic inflammation
International Immunopharmacology, 2020
Designing bisubstrate analog inhibitors for protein kinases
Pharmacology & Therapeutics, 2002
Bioassays for Anticancer Activities
Methods in Molecular Biology, 2013
Anti-Cancer Drugs: Molecular Mechanisms of Action
Mini-Reviews in Medicinal Chemistry, 2005
Extended kinase profile and properties of the protein kinase inhibitor nilotinib
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
Chemotherapy and immunotherapy for acute myelogenous leukemia
Cancer, 1980
Indolin-2-Ones in Clinical Trials as Potential Kinase Inhibitors: A Review
Pharmacology & Pharmacy, 2012
2013
Kinase Inhibition that Hinges on Halogen Bonds
Chemistry & Biology, 2011
Kinase Inhibitors from Marine Sponges
Marine Drugs, 2011
Development of GLUT4-selective antagonists for multiple myeloma therapy
European Journal of Medicinal Chemistry, 2017
The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth
Human Reproduction, 2004
Apoptosis-Induction for Cancer Therapy
Encyclopedia of Cancer
PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity
Clinical Cancer Research, 2006
Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
Bioorganic & Medicinal Chemistry Letters, 2008
Related topics
BiologyCytokinesMedicineDNANitrilesMultiple MyelomaNF-kappa BPhosphorylationCell Proliferation